deaths (OS)

endometrial cancer endometrial cancer

versus placebo plus SoC
atezolizumab plus SoC vs. placebo plus SoC 1 1.0better0.35.093 %

endometrial cancer - (neo)adjuvant (NA) endometrial cancer - (neo)adjuvant (NA)